Accendra Health
188 hedge funds and large institutions have $429M invested in Accendra Health in 2020 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 57 increasing their positions, 53 reducing their positions, and 40 closing their positions.
224% more call options, than puts
Call options by funds: $3.93M | Put options by funds: $1.21M
15% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 40
3% more funds holding
Funds holding: 183 → 188 (+5)
1.47% more ownership
Funds ownership: 87.77% → 89.24% (+1.5%)
8% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 53
15% less capital invested
Capital invested by funds: $506M → $429M (-$77.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$10.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.13M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$4.24M |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$3.6M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$8.78M |
| 2 |
Morgan Stanley
New York
|
-$5M |
| 3 |
Renaissance Technologies
New York
|
-$4.57M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.59M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.58M |
ACH Hedge Fund Activity: Q2 2020 in Review
188 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q2 2020, worth a combined $429M — down 15% from $506M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new ACH positions and 40 closed out — a net gain of 6 holders — while 57 added to existing stakes and 53 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $10.8M. The largest seller was Goldman Sachs, cutting an estimated $8.78M.
- 188 institutional investors held Accendra Health (ACH) as of Q2 2020, up from 183 in Q1 2020.
- Funds reported $429M of Accendra Health stock for Q2 2020, down 15% quarter-over-quarter.
- 46 funds opened new Accendra Health positions in Q2 2020 and 40 closed out, a net change of +6 holders.
- The largest Accendra Health buyer in Q2 2020 was Deerfield Management, an estimated $10.8M added.
- The largest Accendra Health seller in Q2 2020 was Goldman Sachs, an estimated $8.78M sold.
Based on aggregated 13F filings for Q2 2020.